Cognitive and Psychomotor Skills and Behavioural Changes During Ramadan in Women
NCT06865014, Completed, Abant Izzet Baysal University
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Cognitive and Psychomotor Skills and Behavioural Changes During Ramadan in Women | ClinicalTrials.gov |
| NCT number | NCT06865014 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Enrollment | 22 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Abant Izzet Baysal University | ClinicalTrials.gov |
| Conditions | Fasting, Intermittent, Food Habits, Sleep | ClinicalTrials.gov |
| Interventions | Intermittent Ramadan Fasting | ClinicalTrials.gov |
| First posted | 2025-03-07 | ClinicalTrials.gov |
| Last updated | 2025-07-10 | ClinicalTrials.gov |
Registered outcomes 10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Actigraphy | Pre-test, following one week first mid-test, following three weeks second mid-test and following two weeks post-test | Actigraphy is a less invasive method compared to other sleep measurement methods such as polysomnography | ClinicalTrials.gov |
| Primary | Body weight measurement | Pre-test, following one month mid-test and following another one month post-test | Test that involves measuring body weight using medical scales | ClinicalTrials.gov |
| Primary | Body fat percentage | Pre-test, following one month mid-test and following another one month post-test | Includes determination of body fat percentage using a bioelectrical impedance analyzer | ClinicalTrials.gov |
| Primary | Food consumption assessment | Pre-test, following one week first mid-test, following three weeks second mid-test and following two weeks post-test | Participants will be asked to record their food and liquid intake in detail for three consecutive days (two weekdays and one weekend day). All data will then be entered into the nutrition data system, and total energy intake, carbohydrate amount (CHO), protein, fat, and liquid consumption will be calculated. | ClinicalTrials.gov |
| Primary | Stroop test | Pre-test, following one week first mid-test, following three weeks second mid-test and following two weeks post-test | The Stroop test reflects mainly the frontal lobe activity. The Stroop effect demonstrates an individual's ability to shift perceptual setup according to changing demands, suppress habitual response patterns, and perform unconventional actions, which are primarily related to frontal lobe activity. The test also measures information processing speed. | ClinicalTrials.gov |
| Primary | Letter Digit Substitution Test | Pre-test, following one week first mid-test, following three weeks second mid-test and following two weeks post-test | The Letter Digit Substitution Test is an adapted matching test developed to measure information processing speed. The test contains a key containing nine letters of the alphabet and the numbers 1 to 9. Then there are randomly arranged letters and participants will be asked to match the random letters with the appropriate number indicated by the key. | ClinicalTrials.gov |
| Primary | Anticipation time measurement | Pre-test, following one week first mid-test, following three weeks second mid-test and following two weeks post-test | The anticipation time will be measured using the 50575 model of the Bassin Anticipation Timer. The sensitivity of the device will be set to 0.001 seconds, with the anticipation device's speed set to 11 mph (4.9 m/s) and the delay time set to 0-2 seconds. Each participant will undergo 20 measurements per session. Measurements will be manually recorded on the anticipation time measurement sheet. The test position for all participants will be standing vertically in front of the anticipation device, with the motion light approaching them. The participant will stand at the end of the device, using their dominant hand to press the stop button at sternum height with one hand. The researcher will hide the start command button behind them to ensure participants cannot see when the test begins. After each trial is recorded, the next trial will be conducted. The fixed anticipation time error (SzSh) and absolute anticipation time error (SzMh) will be automatically calculated. | ClinicalTrials.gov |
| Primary | Physical activity level assessment | Pre-test, following one week first mid-test, following three weeks second mid-test and following two weeks post-test | The International Physical Activity Questionnaire (IPAQ) will be used to determine their level of physical activity levels. The questionnaire consists of sections that inquire about vigorous physical activity, moderate physical activity, and walking activities of at least 10 minutes duration over the past seven days. | ClinicalTrials.gov |
| Secondary | Pittsburgh Sleep Quality Index (PSQI) | Pre-test, following one month mid-test and following another one month post-test | Pittsburgh Sleep Quality Index assesses various sleep-related factors, including sleep latency, sleep duration, sleep efficiency, and daytime sleepiness. It is a 19-item self-report questionnaire. Each item is scored from 0 to 3, and the total score ranges from 0 to 57. Higher scores indicate poorer sleep quality. | ClinicalTrials.gov |
| Secondary | Chronotype assessment | Only once in the pre-test | Morningness-Eveningness Questionnaire (MEQ) will be used to assess Chronotype. The form consists of 19 questions, each offering four possible answers. Participants receive different scores based on their responses: questions 3, 4, 5, 6, 7, 8, 9, 13, 14, 15, and 16 are scored between 1 and 4, questions 1, 2, 10, 17, and 18 are scored between 1 and 5, questions 11 and 19 are scored between 0 and 6, and question 12 is scored between 0 and 5. The scores range from 16 to 86, with lower scores indicating evening types and higher scores indicating morning types. Based on the total score, individuals are classified as evening types (16-41 points), intermediate types (42-58 points), and morning types (59-86 points). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)